Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

bremelanotide MeSH Supplementary Concept Data 2025


MeSH Supplementary
bremelanotide
Unique ID
C476721
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C476721
Entry Term(s)
PT-141
Vyleesi
Registry Numbers
6Y24O4F92S
0
Heading Mapped to
*alpha-MSH
*Peptides, Cyclic
Frequency
43
Note
a synthetic peptide analogue of alpha-MSH, is an agonist at melanocortin receptors including the MC3R and MC4R, which are expressed primarily in the central nervous system;
Source
Ann N Y Acad Sci. 2003 Jun;994():96-102
J Sex Med. 2006 Jul;3(4):628-38
Indexing Information
Receptor, Melanocortin, Type 3
Receptor, Melanocortin, Type 4
Date of Entry
2003/08/28
Revision Date
2019/08/28
bremelanotide Preferred
PT-141 Narrower
Vyleesi Related
page delivered in 0.005s